Cloud computing-Role in Drug discovery
Cloud computing can be the drug discovery game changer as foreseen by Paul Davey -the chief executive officer at InhibOx Ltd.Nimbus Thinks It Can Cure Obesity With Cloud Computing; Next Up, an Exercise Pill....
iScreen: world's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan.The Virtual Laboratory Project is working to enable "Molecular Modelling for Drug Design" on the World Wide Grid...
iScreen is the world's first web server that employs world's largest TCM database for virtual screening and de novo drug design. It is believed that this web server can lead TCM research to a new era of drug development. The TCM docking and screening server is available at http://iScreen.cmu.edu.tw/ .
iScreen: world's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan.The Virtual Laboratory Project is working to enable "Molecular Modelling for Drug Design" on the World Wide Grid...
iScreen is the world's first web server that employs world's largest TCM database for virtual screening and de novo drug design. It is believed that this web server can lead TCM research to a new era of drug development. The TCM docking and screening server is available at http://iScreen.cmu.edu.tw/ .
Let’s start with a refresher, and make the link between high-throughput screening, computer-aided
drug discovery and cloud computing along the way. The scientists behind developing CADD systems have always been grasping for more computing power, to make practical their developments. Ten years ago, Professor Graham Richards at Oxford University was leading the screen-saver project (9), pulling spare CPU power from over three million PCs across the world to drive virtual screening of cancer drug candidates. Cloud computing makes that amazing vision a practical, commercial reality. At last, computing power is available and cost-effective enough to cause the design of
modelling systems to be fundamentally reassessed. It should herald the development of no-compromise
CADD and effective virtual screening – and that could indeed change the drug discovery game.
drug discovery and cloud computing along the way. The scientists behind developing CADD systems have always been grasping for more computing power, to make practical their developments. Ten years ago, Professor Graham Richards at Oxford University was leading the screen-saver project (9), pulling spare CPU power from over three million PCs across the world to drive virtual screening of cancer drug candidates. Cloud computing makes that amazing vision a practical, commercial reality. At last, computing power is available and cost-effective enough to cause the design of
modelling systems to be fundamentally reassessed. It should herald the development of no-compromise
CADD and effective virtual screening – and that could indeed change the drug discovery game.
0 comments:
Post a Comment